News for Panacea Biotec Limited (PANACEABIO.BO)

In the Nifty 50 index, 41 stocks were trading in the green, while 9 stocks were trading in the red.

The Nifty Auto index was trading 0.72 per cent up at 21527.55.

In the Nifty50 index, 38 stocks were trading in the green, while 12 stocks were in the red.

The Nifty Realty index was trading 0.02 per cent down at 840.65.

In the Nifty 50 index, 15 stocks were trading in the green, while 35 stocks were trading in the red.

The Nifty IT index was trading 0.49 per cent down at 33111.2.

Hindalco, Infosys, JSW Steel, Maruti Suzuki and Hero MotoCorp were among the top losers on NSE.

In the Nifty pack, 19 stocks were trading in the green, while 31 stocks were trading in the red.

The Nifty Realty index was trading 0.29 per cent up at 837.15.

The Nifty Bank index was trading 0.61 per cent up at 52700.45.

In the Nifty 50 index, 21 stocks were trading in the green, while 29 stocks were trading in the red.

Panacea Biotec, Sangam Renewables, NACL Industries, Gallantt Metal and Narayana Hruday, hit their fresh 52-week highs at 10:14AM.

In the Nifty50 index, 27 stocks were trading in the green, while 23 stocks were in the red.

The Nifty Pharma index was trading 0.12 per cent up at 20936.8.

The Nifty Auto index was trading 0.36 per cent down at 21169.4.

Seventeen smallcap stocks have turned multibaggers since Modi 3.0's first budget, delivering over 100% returns despite a market downturn. Companies like Marsons, Pacheli Industrial Finance, and Kitex Garments lead the gains, with notable rallies of over 200%. Investors are advised to moderate return expectations while adopting a

Panacea Biotec's shares are in focus as the company receives a Letter of Award from UNICEF for supplying 115 million doses of its bivalent oral polio vaccine (bOPV) worth approximately US$ 14.95 million (Rs 127 crore) in CY2025. The company recently posted a profit of Rs 4.8 crore, marking a strong recovery after three quarters of losses.

Panacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involved Panacea's claim that Sanofi's Shan6 vaccine infringed on its EasySix patent. Sanofi agreed not to market the infringing product and withdrew its opposition to Panacea's patent amendment.

The shares of Panacea Biotec rose after the company announced that it has secured $20 million in loan from US International Development Finance Corp (DFC).